AbbVie would gain an experimental eczema drug by buying biotech: report
Jaimy Lee
·
2026-06-21
·
via MarketWatch.com - Top Stories
Apogee Therapeutics, which is developing a promising atopic dermatitis drug, saw its stock close nearly 47% h…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。